Första AP-fonden’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,300
| Closed | -$2.09M | – | 561 |
|
|
2024
Q4 | $2.09M | Buy |
11,300
+700
| +7% | +$129K | 0.01% | 540 |
|
|
2024
Q3 | $2.09M | Buy |
10,600
+1,100
| +12% | +$217K | 0.02% | 533 |
|
|
2024
Q2 | $1.96M | Sell |
9,500
-800
| -8% | -$165K | 0.02% | 523 |
|
|
2024
Q1 | $2.79M | Buy |
10,300
+1,500
| +17% | +$406K | 0.02% | 506 |
|
|
2023
Q4 | $2.08M | Buy |
+8,800
| New | +$2.08M | 0.02% | 531 |
|
|
2022
Q3 | – | Sell |
-11,200
| Closed | -$2.4M | – | 590 |
|
|
2022
Q2 | $2.4M | Buy |
+11,200
| New | +$2.4M | 0.03% | 489 |
|
|
2022
Q1 | – | Sell |
-10,100
| Closed | -$3.81M | – | 574 |
|
|
2021
Q4 | $3.81M | Sell |
10,100
-11,300
| -53% | -$4.26M | 0.04% | 444 |
|
|
2021
Q3 | $8.83M | Buy |
21,400
+6,300
| +42% | +$2.6M | 0.1% | 238 |
|
|
2021
Q2 | $5.59M | Buy |
+15,100
| New | +$5.59M | 0.07% | 356 |
|